Marvelon

Desogestrel/Ethinylestradiol, the active ingredient in Marvelon, is a combined oral contraceptive presented as a 0.15 mg desogestrel / 0.02 mg ethinylestradiol oral tablet for oral use. It prevents pregnancy and helps regulate the menstrual cycle in women of reproductive age.

GNH USA supplies Marvelon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, offering consistent quality and regulatory‑approved batches to meet the needs of qualified prescribers and health‑care systems.

Marvelon, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy and manage menstrual cycles.

- Contraception: provides reliable prevention of ovulation and pregnancy in women of reproductive age. - Regulation of menstrual cycle: promotes more regular periods and reduces heavy bleeding. - Premenstrual syndrome (PMS): alleviates mood swings, breast tenderness and other PMS symptoms.

Common Side Effects: - Nausea: mild stomach upset that usually resolves with continued use. - Headache: transient tension‑type headaches reported by some users. - Breast tenderness: temporary swelling or discomfort of the breasts. - Irregular bleeding: spotting or breakthrough bleeding during the initial cycles.

Serious or Rare Side Effects: - Deep vein thrombosis: formation of blood clots in deep veins, requiring immediate medical attention. - Pulmonary embolism: clot migration to the lungs, a life‑threatening emergency. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and breathing difficulty.

Before prescribing Marvelon, clinicians should consider the following precautions: - Assess thrombotic risk: evaluate personal and family history of venous clotting disorders. - Screen for hypertension: uncontrolled high blood pressure contraindicates use. - Check liver function: avoid in active liver disease or severe hepatic impairment. - Avoid smoking: especially in women over 35 years of age. - Review medication list: identify drugs that may alter contraceptive effectiveness. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Marvelon may interact with several medicines that affect hormone metabolism or clotting risk.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): markedly reduce contraceptive efficacy. - Rifampicin: decreases hormone levels, increasing the risk of unintended pregnancy. - Protease inhibitor antiretrovirals (e.g., ritonavir): may raise hormone concentrations and heighten side‑effect risk.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): can increase hormone levels, requiring monitoring for adverse effects. - St. John’s wort: may lower contraceptive effectiveness, necessitating alternative birth control. - Macrolide antibiotics (e.g., erythromycin): possible alteration of liver enzymes, warranting observation.